32.29 USD
↘ 1.09 (3.27%)AT CLOSE (11:59 AM EDT)
Vera Therapeutics, Inc. Class A Common Stock
VERANASDAQ • USD
32.55
↗ 0.26 (0.82%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
32.55
↗ 0.26 (0.82%)
Market: CLOSED
Open?$33.38
High?$34.06
Low?$31.40
Prev. Close?$33.38
Volume?1.5M
Avg. Volume?1.1M
VWAP?$32.22
Rel. Volume?1.33x
Bid / Ask
Bid?$31.60 × 100
Ask?$32.51 × 300
Spread?$0.91
Midpoint?$32.06
Valuation & Ratios
Market Cap?2.3B
Shares Out?71.8M
Float?62.9M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?4.64
EPS?-$5.15
Dividend?0.00%
Ex-Dividend?N/A
Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $32.29 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, VERA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005
Phone: 650-770-0077
BRISBANE, CA 94005
Phone: 650-770-0077
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?20
Piotroski F-Score?0/9Weak
Altman Z-Score?8.48Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?16.02%High
Short Interest?10.1M
Days to Cover?10.0
Free Float62.9M
Avg Daily Volume1.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?13.64Strong
Quick Ratio?13.64Strong
Cash Ratio?2.53Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.64FAIR▾
Peers100
S&P39
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-74.0%WEAK▾
S&P3
ROA?-59.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-293814000
Enterprise Value?$2.3B
Fundamentals ratios updated end of day